Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Sucampo Pharmaceuticals, Inc.    SCMP   US8649091068

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/18/2015 05/19/2015 05/20/2015 05/21/2015 05/22/2015 Date
16.04(c) 16.13(c) 15.96(c) 15.93(c) 15.85(c) Last
350 604 299 692 267 639 172 522 168 661 Volume
+0.63% +0.56% -1.05% -0.19% -0.50% Change
More quotes
Financials ($)
Sales 2015 132 M
EBIT 2015 45,7 M
Net income 2015 28,8 M
Debt 2015 -
Yield 2015 -
Sales 2016 153 M
EBIT 2016 59,8 M
Net income 2016 37,9 M
Debt 2016 -
Yield 2016 -
PER 2015 25,36
PER 2016 19,39
Capi. / Sales 2015 5,43x
Capi. / Sales 2016 4,67x
Capitalization 716 M
More Financials
Company
Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company which engages in research, discovery, development and commercialization of proprietary drugs in the Americas, Europe and Asia.It is developing prostones, which are ion channel activators, to treat gastrointestinal, ophthalmic and... 
More about the company
Surperformance© ratings of Sucampo Pharmaceuticals, I
Trading Rating : Investor Rating :
More Ratings
Latest news on SUCAMPO PHARMACEUTICALS, I
05/20 SUCAMPO PHARMACEUTICALS : Regulation FD Disclosure, Financial Statements and Exh..
05/16 SUCAMPO PHARMACEUTICALS : Announces Clinical Data on Lubiprostone to be Presente..
05/15 Sucampo Announces Clinical Data on Lubiprostone to be Presented at Digestive ..
05/14 R TECH UENO : Termination of License Agreements for Unoprostone
05/13 Sucampo Announces Webcast of Its Presentation at the 2015 UBS Global Healthca..
05/13 HARBIN GLORIA PHARMACEUTICALS : Becomes Swiss Drug Maker China Agent
05/12 Sucampo and Harbin Gloria Pharmaceuticals Enter Into Licensing Agreement for ..
05/11 SUCAMPO PHARMACEUTICALS : Entry into a Material Definitive Agreement, Financial ..
More news
Sector news : Bio Therapeutic Drugs
05/24 QUINTILES TRANSNATIONAL : Launches New Solution to Meet Needs of Asia-Pacific Em..
05/22 SYNAGEVA BIOPHARMA : SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investiga..
05/22 BLUEBIRD BIO : Announces Participation at the Jefferies 2015 Global Healthcare C..
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
05/17 WEEK IN REVIEW : BeiGene Raises $97 Million For Cancer Drugs
05/08 SEEKING ALPHA'S BIOTECH WEEKLY : Celgene's Future, Northwest Bio's Science, And ..
05/07 Sucampo's cobiprostone Fast Track'd for prevention of oral mucositis
05/07 Midday Gainers / Losers
05/07 Healthcare ratings roundup


Comments 
Advertisement
Chart SUCAMPO PHARMACEUTICALS, I
Duration : Period :
Sucampo Pharmaceuticals, I Technical Analysis Chart | SCMP | US8649091068 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions